INS and metabolic dysfunction-associated steatotic liver disease: Clinically, the drugs such as hypoglycemic, lipid-lowering, and insulin sensitizers are usually chosen during the NAFLD treatment; at the same time, diet control and exercise are necessary [10, 29].